49 related articles for article (PubMed ID: 19143681)
41. Importance of measuring products of non-enzymatic glycation of proteins.
Lapolla A; Traldi P; Fedele D
Clin Biochem; 2005 Feb; 38(2):103-15. PubMed ID: 15642271
[TBL] [Abstract][Full Text] [Related]
42. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies.
Pertyńska-Marczewska M; Głowacka E; Sobczak M; Cypryk K; Wilczyński J
Am J Reprod Immunol; 2009 Feb; 61(2):175-82. PubMed ID: 19143681
[TBL] [Abstract][Full Text] [Related]
43. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
Yamagishi S; Matsui T; Nakamura K
Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
[TBL] [Abstract][Full Text] [Related]
44. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
Stern DM; Yan SD; Yan SF; Schmidt AM
Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
[TBL] [Abstract][Full Text] [Related]
45. The possible impact of advanced glycation end products on pregnancy outcome in women with diabetes mellitus type 1.
Pertynska-Marczewska M; Cypryk K
Minerva Endocrinol; 2017 Sep; 42(3):271-279. PubMed ID: 27304070
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
47. Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.
Geroldi D; Falcone C; Emanuele E
Curr Med Chem; 2006; 13(17):1971-8. PubMed ID: 16842191
[TBL] [Abstract][Full Text] [Related]
48.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
49.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
